Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke
Stroke2007Vol. 38(10), pp. 2633–2639
Citations Over TimeTop 1% of 2007 papers
Akira Ogawa, Etsuro Mori, Kazuo Minematsu, Waro Taki, Akira Takahashi, Shigeru Nemoto, Susumu Miyamoto, Makoto Sasaki, Takashi Inoue
Abstract
The trial was aborted prematurely and the primary end point did not reach statistical significance. Nevertheless, the secondary analyses suggested that intraarterial fibrinolysis has the potential to increase the likelihood of excellent functional outcome.
Related Papers
- → Decompressive craniotomy for the treatment of malignant infarction of the middle cerebral artery: mortality and outcome(2017)16 cited
- → The clinical outcome of emergency superficial temporal artery-to-middle cerebral artery bypass in acute ischemic stroke with large vessel occlusion(2024)5 cited
- [Intravenous tissue plasminogen activator in the treatment of acute ischemic stroke: feasibility, safety, and efficiency in the 2 first years of the clinical practice].(1999)
- Thrombolysis with urokinase for acute ischemic stroke patients with atrial fibrillation(2012)
- 혈중 Urokinase 농도와 Plasmin 형성에 관한 연구(1992)